DJIA 16,493.37 -69.93 -0.42%
NASDAQ 4,352.64 -17.13 -0.39%
S&P 500 1,925.15 -5.52 -0.29%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

61.95 0.13 (0.21%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $61.95 0.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.03
Previous Close $61.82
Daily Range $61.03 - $62.93
52-Week Range $55.04 - $84.25
Market Cap $9.0B
P/E Ratio -46.83
Dividend (Yield) $0.00 (0.0%)
Volume 1,058,398
Average Daily Volume 1,120,163
Current FY EPS -$1.75

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary

Can Alexion Pharmaceuticals Remain a Top Orphan Drugmaker in the Years Ahead?

Can Alexion Pharmaceuticals retain its top orphan drug maker status, or will this one trick pony lose its audience?

BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog

BioMarin Pharmaceutical's (BMRN) CEO Jean-Jacques Bienaimé on Q2 2014 Results - Earnings Call Transc

BioMarin Pharmaceutical's (BMRN) CEO Jean-Jacques Bienaimé on Q2 2014 Results - Earnings Call Transcript

Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blo

Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog

Incyte's Jakafi Fails to Provide RELIEF in Polycythemia Vera - Analyst Blog

Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines - Analyst Blog

Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape

Zacks Rank #1 Additions for Friday - Tale of the Tape

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

See More BMRN News...

BMRN's Top Competitors

BMRN $61.95 (0.21%)
Current stock: BMRN
AMGN $125.55 (-1.44%)
Current stock: AMGN
GILD $91.50 (-0.05%)
Current stock: GILD
BIIB $329.83 (-1.36%)
Current stock: BIIB